Early research (Phase 1)Study completedNCT00346853What this trial is testingPhase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyWho this might be right forMacular Dystrophy, Corneal University of Utah 10
Large-scale testing (Phase 3)Looking for participantsNCT07419334What this trial is testingStudy of ALK-001 on the Progression of Stargardt DiseaseWho this might be right forStargardt Disease Alkeus Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Looking for participantsNCT07002398What this trial is testingSafety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)Who this might be right forRetinal Dystrophy Due to Biallelic ABCA4 MutationsStargardt Disease 1 VeonGen Therapeutics GmbH 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300476What this trial is testingSafety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)Who this might be right forStargardt Disease 1 West China Hospital 9
Not applicableLooking for participantsNCT06435000What this trial is testingAn Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 GeneWho this might be right forStargardtStargardt's DiseaseStargardt Disease+1 more Splice Bio 75
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02402660What this trial is testingPhase 2 Tolerability and Effects of ALK-001 on Stargardt DiseaseWho this might be right forStargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more Alkeus Pharmaceuticals, Inc. 160
Not applicableActive Not RecruitingNCT05674058What this trial is testingFunction and Imaging Assessments for G1961E-associated Stargardt DiseaseWho this might be right forStargardt DiseaseStargardt Disease 1Fundus Flavimaculatus+2 more University Hospital, Basel, Switzerland 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05956626What this trial is testingA Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseWho this might be right forStargardt Disease Ocugen 51
Testing effectiveness (Phase 2)Looking for participantsNCT06942572What this trial is testingA Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)Who this might be right forStargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy Splice Bio 57
Not applicableStudy completedNCT03297515What this trial is testingTherapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt DiseaseWho this might be right forDry AMDStargardt Disease 1 Ophthalmos Research and Education Institute 32
Not applicableUnknownNCT04281732What this trial is testingVisual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced VisionWho this might be right forLow VisionRetinitis PigmentosaStargardt Disease 1+3 more Queen's University, Belfast 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04239625What this trial is testingOpen-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)Who this might be right forStargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more Alkeus Pharmaceuticals, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06467344What this trial is testingStudy to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)Who this might be right forStargardt DiseaseCone Rod DystrophyJuvenile Macular Degeneration+1 more Ascidian Therapeutics, Inc 15
Not applicableLooking for participantsNCT06445322What this trial is testingPrescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)Who this might be right forStargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more Ascidian Therapeutics, Inc 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06388083What this trial is testingEvaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt DiseaseWho this might be right forSTGD1Stargardt Disease 1 Belite Bio, Inc 60
Early research (Phase 1)Study completedNCT02230228What this trial is testingPhase 1 Safety Study of ALK-001 in Healthy VolunteersWho this might be right forStargardt DiseaseAge-related Macular DegenerationOther Retinal Dystrophies Alkeus Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05266014What this trial is testingThis is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt DiseaseWho this might be right forStargardt Disease RBP4 Pty Ltd 13
Testing effectiveness (Phase 2)Looking for participantsNCT07439887What this trial is testingPhase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt DiseaseWho this might be right forStargardt Disease Ray Therapeutics, Inc. 18
Large-scale testing (Phase 3)Study completedNCT05244304What this trial is testingPhase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt DiseaseWho this might be right forStargardt Disease 1 Belite Bio, Inc 104
Early research (Phase 1)UnknownNCT03772938What this trial is testingStem Cells Therapy in Degenerative Diseases of the RetinaWho this might be right forRetinal DegenerationRetinitis PigmentosaAge Related Macular Degeneration+1 more Pomeranian Medical University Szczecin 30